Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report

Windtree Therapeutics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Windtree Therapeutics Inc (Windtree Therapeutics) is a biopharmaceutical and medical device company that focuses on developing its drug product candidates for the treatment of pulmonary and cardiovascular diseases. The company’s four lead development programs are istaroxime, for treating acute decompensated heart failure (ADHF); Aerosurf, a lucinactant for inhalation, and lyophilized KL4 surfactant intratracheal suspension, both for treating respiratory distress syndrome (RDS) in premature infants; and rostafuroxin for treating genetically associated hypertension. The company uses its proprietary technology platform Aerosol Delivery System (ADS) with pulmonary surfactants or in combination with other products to treat pediatric and adult respiratory disorders. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Scope

  • Detailed information on Windtree Therapeutics Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Windtree Therapeutics Inc in the form of a SWOT analysis
  • An in-depth view of the business model of Windtree Therapeutics Inc including a breakdown and examination of key business segments
  • News about Windtree Therapeutics Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Windtree Therapeutics Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Windtree Therapeutics Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Windtree Therapeutics Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda UK Ltd

Sandoz Ltd

RespireRx Pharmaceuticals Inc

Ony Inc

Chiesi Farmaceutici SpA

ANI Pharmaceuticals Inc

Takeda UK Ltd

Sandoz Ltd

RespireRx Pharmaceuticals Inc

Ony Inc

Chiesi Farmaceutici SpA

ANI Pharmaceuticals Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Windtree Therapeutics Inc - Key Facts

Windtree ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Windtree Therapeutics Inc - Key Facts

Windtree Therapeutics Inc - Key Employees

Windtree Therapeutics Inc - Key Employee Biographies

Windtree Therapeutics Inc - Major Products and Services

Windtree Therapeutics Inc - History

Windtree Therapeutics Inc - Company Statement

Windtree Therapeutics Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Windtree Therapeutics Inc - Business Description

Windtree Therapeutics Inc - SWOT Analysis

SWOT Analysis - Overview

Windtree Therapeutics Inc - Strengths

Windtree Therapeutics Inc - Weaknesses

Windtree Therapeutics Inc - Opportunities

Windtree Therapeutics Inc - Threats

Windtree Therapeutics Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Windtree Therapeutics Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 14, 2019: Windtree Therapeutics reports second quarter 2019 financial results and provides key business updates

May 20, 2019: Windtree Therapeutics reports first quarter 2019 financial results and provides key business updates

Apr 30, 2019: Windtree Therapeutics appoints Daniel Geffken to Board of Directors

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Windtree Therapeutics Inc, Key Facts

Windtree Therapeutics Inc, Key Employees

Windtree Therapeutics Inc, Key Employee Biographies

Windtree Therapeutics Inc, Major Products and ...

List of Tables

Windtree Therapeutics Inc, Key Facts

Windtree Therapeutics Inc, Key Employees

Windtree Therapeutics Inc, Key Employee Biographies

Windtree Therapeutics Inc, Major Products and Services

Windtree Therapeutics Inc, History

Windtree Therapeutics Inc, Other Locations

Windtree Therapeutics Inc, Subsidiaries

Windtree Therapeutics Inc, Key Competitors

Windtree Therapeutics Inc, Ratios based on current share price

Windtree Therapeutics Inc, Annual Ratios

Windtree Therapeutics Inc, Annual Ratios (Cont...1)

Windtree Therapeutics Inc, Interim Ratios

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Windtree Therapeutics Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Windtree Therapeutics Inc, Performance Chart (2014 - 2018)

Windtree Therapeutics Inc, Ratio Charts

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, ...

List of Figures

Windtree Therapeutics Inc, Performance Chart (2014 - 2018)

Windtree Therapeutics Inc, Ratio Charts

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports